This information sheet indicates how the course will be organized at pandemic code level yellow and green.
If the colour codes change during the academic year to orange or red, modifications are possible, for example to the teaching and evaluation methods.

Pharmaco therapy and pharmaceutical care I

Course Code :2001FBDFGO
Study domain:Pharmaceutical Sciences
Academic year:2020-2021
Semester:2nd semester
Sequentiality:Cannot be followed with 2nd bachelor courses
Contact hours:57
Study load (hours):196
Contract restrictions: Exam contract not possible
Credit required to obtain degree: Credit required: Yes
Language of instruction:Dutch
Exam period:exam in the 2nd semester
Lecturer(s)Guido De Meyer
Hans De Loof

3. Course contents *

Pharmacotherapy and pharmaceutical care are taught in an integrated manner in this programme component. Pharmaceutical care is the responsible delivery of prescribed medicines or medicines that can be delivered without a prescription, with a view to, in consultation with other healthcare providers and the patient, the achievement of general health objectives, such as prevention, identification, and solving problems associated with the use of medicines. Pharmaceutical care aims to continuously improve the use of medicines and to preserve or improve the quality of life of patients. Inter-professional consultation includes, among other things, referral to a doctor and informing the attending physician.

This programme component is taught as much as possible on the basis of the most common syndromes. The medicines eligible for treatment, both self-care medicines and prescription medicines, are thoroughly discussed with the emphasis on advice for the responsible use of medicines.

The following topics are discussed:

(1) Indications, posology and time of administration of medicines.
(2) Therapy structure and initiation of treatment.
(3) Side effects of medicines and how to treat them.
(4) Drug interactions (clinical relevance, explanation, proposal of alternative) and interactions with nutrition.
(5) Comparison of medicinal products within a class. Guidance for justifying a particular choice.
(6) Co-morbidity.
(7) Contraindications.
(8) Decline and/or switch to another medicinal product.
(9) New medicinal products within a class.
(10) Medication monitoring and therapy compliance.
(11) Use of medicines during pregnancy and lactation.